Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


| Molecular Weight | 225.20 g/mol |
|---|---|
| Molecular Formula | C8H11N5O3 |
| XLogP3 | -1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 225.08618923 g/mol |
| Monoisotopic Mass | 225.08618923 g/mol |
| Topological Polar Surface Area | 115 A^2 |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 308 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 8 | |
|---|---|
| Drug Name | Acyclovir |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Capsule; Suspension |
| Route | Topical; Oral |
| Strength | 5%; 200mg/5ml; 200mg; 800mg; 400mg |
| Market Status | Prescription |
| Company | Amneal Pharms; Mylan Pharms; Ranbaxy; Hetero Labs Ltd V; Hi Tech Pharma; Actavis Mid Atlantic; Teva; Cadila Pharms; Apotex; Zydus Pharms Usa; Carlsbad; Mylan; Stason; Dava Pharms |
| 2 of 8 | |
|---|---|
| Drug Name | Acyclovir sodium |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
| Active Ingredient | Acyclovir sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
| 3 of 8 | |
|---|---|
| Drug Name | Sitavig |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | SITAVIG (acyclovir) buccal tablet is applied topically to the gum and releases acyclovir as the buccal tablet gradually dissolves [see ClinicalPharmacology (12.3)]. Acyclovir is a synthetic purine nucleoside analogue active against herpes viruses. Th... |
| Active Ingredient | Acyclovir |
| Dosage Form | Tablet |
| Route | Buccal |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Innocutis Holdings |
| 4 of 8 | |
|---|---|
| Drug Name | Zovirax |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Cream; Capsule; Suspension |
| Route | Oral; Topical |
| Strength | 200mg/5ml; 200mg; 800mg; 400mg; 5% |
| Market Status | Prescription |
| Company | Delcor Asset; Valeant Bermuda |
| 5 of 8 | |
|---|---|
| Drug Name | Acyclovir |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Capsule; Suspension |
| Route | Topical; Oral |
| Strength | 5%; 200mg/5ml; 200mg; 800mg; 400mg |
| Market Status | Prescription |
| Company | Amneal Pharms; Mylan Pharms; Ranbaxy; Hetero Labs Ltd V; Hi Tech Pharma; Actavis Mid Atlantic; Teva; Cadila Pharms; Apotex; Zydus Pharms Usa; Carlsbad; Mylan; Stason; Dava Pharms |
| 6 of 8 | |
|---|---|
| Drug Name | Acyclovir sodium |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
| Active Ingredient | Acyclovir sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
| 7 of 8 | |
|---|---|
| Drug Name | Sitavig |
| PubMed Health | Acyclovir |
| Drug Classes | Antiviral |
| Drug Label | SITAVIG (acyclovir) buccal tablet is applied topically to the gum and releases acyclovir as the buccal tablet gradually dissolves [see ClinicalPharmacology (12.3)]. Acyclovir is a synthetic purine nucleoside analogue active against herpes viruses. Th... |
| Active Ingredient | Acyclovir |
| Dosage Form | Tablet |
| Route | Buccal |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Innocutis Holdings |
| 8 of 8 | |
|---|---|
| Drug Name | Zovirax |
| Drug Label | ZOVIRAX is the brand name for acyclovir, a synthetic nucleoside analogue active against herpesviruses. ZOVIRAX Cream 5% is a formulation for topical administration. Each gram of ZOVIRAXCream 5% contains 50mg of acyclovir and the following inactiv... |
| Active Ingredient | Acyclovir |
| Dosage Form | Ointment; Tablet; Cream; Capsule; Suspension |
| Route | Oral; Topical |
| Strength | 200mg/5ml; 200mg; 800mg; 400mg; 5% |
| Market Status | Prescription |
| Company | Delcor Asset; Valeant Bermuda |
Apex Healthcare Limited: ISO 9001:2008, WHO-GMP, US FDA-audited manufacturer & exporter of APIs, bulk drugs, and formulations.
Date of Issue : 2024-03-01
Valid Till : 2026-12-31
Written Confirmation Number : WC-0409
Address of the Firm :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10124
Submission : 1993-03-02
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10710
Submission : 1994-02-07
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11974
Submission : 1996-05-08
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2015-03-03
Pay. Date : 2014-04-22
DMF Number : 10685
Submission : 1994-01-12
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2014-02-07
Pay. Date : 2014-01-29
DMF Number : 8584
Submission : 1990-05-25
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2014-05-29
Pay. Date : 2013-06-04
DMF Number : 10044
Submission : 1993-01-12
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-05-09
Pay. Date : 2013-04-26
DMF Number : 11896
Submission : 1996-03-18
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10830
Submission : 1994-03-24
Status : Active
Type : II

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11352
Submission : 1995-02-20
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9530
Submission : 1992-01-03
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 1997-084 - Rev 12
Status : Valid
Issue Date : 2024-05-30
Type : Chemical
Substance Number : 968
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 1997-125 - Rev 04
Status : Withdrawn by Holder
Issue Date : 2011-03-15
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2008-169 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2011-03-15
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2003-041 - Rev 05
Status : Valid
Issue Date : 2020-10-20
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 1998-126 - Rev 03
Status : Valid
Issue Date : 2017-04-27
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2007-213 - Rev 01
Status : Valid
Issue Date : 2018-03-21
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2002-004 - Rev 01
Status : Expired
Issue Date : 2004-11-30
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 1997-031 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2005-02-10
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 1998-148 - Rev 05
Status : Valid
Issue Date : 2016-12-08
Type : Chemical
Substance Number : 968

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2000-086 - Rev 01
Status : Expired
Issue Date : 2004-12-13
Type : Chemical
Substance Number : 968

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Registration Number : 306MF10109
Registrant's Address : Tongyuanxi, Dazhan, Xianju, Zhejiang Province, 317321, P. R. China.
Initial Date of Registration : 2024-08-07
Latest Date of Registration : 2024-08-07

Registration Number : 218MF10098
Registrant's Address : Tongyuanxi, Dazhan, Xianju, Zhejiang Province, 317321, P. R. China.
Initial Date of Registration : 2006-01-30
Latest Date of Registration : 2014-10-27

Registration Number : 218MF10016
Registrant's Address : Strada Rivoltana, km 6/7, 20053 Rodano (MI), Italy
Initial Date of Registration : 2006-01-27
Latest Date of Registration : 2022-01-11

Registration Number : 303MF10178
Registrant's Address : Strada Rivoltana, km 6/7, 20053 Rodano (MI), Italy
Initial Date of Registration : 2021-12-15
Latest Date of Registration : 2021-12-15

Registration Number : 217MF10746
Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY
Initial Date of Registration : 2005-10-07
Latest Date of Registration : 2015-07-13

Registration Number : 218MF10974
Registrant's Address : Plot No. 564/A/22, Road No. 92, Jubilee Hills, Hyderabad-500096, Telangana, India
Initial Date of Registration : 2006-12-01
Latest Date of Registration : 2013-01-18

Registration Number : 221MF10178
Registrant's Address : 59, You Shih Road, Youth Industrial District, Dajia, Taichung, Taiwan 43767, R. O. C.
Initial Date of Registration : 2009-08-07
Latest Date of Registration : 2017-07-25

Registration Number : 221MF10074
Registrant's Address : 66 Guoshan Road, Xinshi Town, Deqing, Zhejiang, China
Initial Date of Registration : 2009-04-14
Latest Date of Registration : 2009-04-14

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Apex Healthcare Limited: ISO 9001:2008, WHO-GMP, US FDA-audited manufacturer & exporter of APIs, bulk drugs, and formulations.
Date of Issue : 2024-03-01
Valid Till : 2026-12-31
Written Confirmation Number : WC-0409
Address of the Firm : 4710, 4711, 4707-A/8, 4707-A/9, GIDC, Industrial Estate, Ankleshwar, Dist.Bharuc...
Date of Issue : 2025-07-11
Valid Till : 2028-07-10
Written Confirmation Number : WC-0220
Address of the Firm : Plot N-37, Additional Ambernath Industrial Area, MIDC, Anand Nagar, MMR Zone-ll,...

Date of Issue : 2022-09-12
Valid Till : 2025-08-12
Written Confirmation Number : WC-0542
Address of the Firm : Plot No. 180/2 & 3, Khazipally (V), Jinnaram (M), Sangareddy - 502 319, Telangan...

Date of Issue : 2022-09-12
Valid Till : 2025-08-12
Written Confirmation Number : WC-0542
Address of the Firm : Plot No. 180/2 & 3, Khazipally (V), Jinnaram (M), Sangareddy - 502 319, Telangan...

Date of Issue : 2022-09-30
Valid Till : 2025-08-08
Written Confirmation Number : WC-0066
Address of the Firm : Plot No 1, Hetero Infrastructure SEZ Ltd., N. Narasapuram, Anakapalli -531081, A...

Acyclovir for Injection (Lyophilsed Sterile Bulk) USP
Date of Issue : 2024-05-20
Valid Till : 2027-05-19
Written Confirmation Number : WC-0275
Address of the Firm : N-211/2/10, Taluka: MIDC Tarapur Boisar-401506, District: Thane-Zone 4, Maharash...

Date of Issue : 2024-03-21
Valid Till : 2027-03-20
Written Confirmation Number : WC-0473
Address of the Firm : Unit-2, Plot No 1203, Ill Phase GIDC, Vapi -396195, Dist.-Valsad, Gujarat, India

Date of Issue : 2024-04-23
Valid Till : 2027-04-01
Written Confirmation Number : WC-0420
Address of the Firm : Plot no. A-619 & 630, RIICO Industrial Area, Bhiwadi -301019, Dist -Alwar, Rajas...

Date of Issue : 2022-08-16
Valid Till : 2025-07-15
Written Confirmation Number : WC-0042N
Address of the Firm : Plot Nos. 262 to 271, IDA, Pashamylaram, Sangareddy District- 502 307, Telangana...

Date of Issue : 2021-12-16
Valid Till : 2024-05-20
Written Confirmation Number : WC-0303n
Address of the Firm : Plant-1, Plot No 1416 to 1421, 1507/1&2, 1601, Phase-lll, GIDC estate, Vapi, Val...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
5'-Chloro-2'-nitro-N-phenylmalonanilic acid ethyl ...
CAS Number : 22316-45-6
End Use API : Acyclovir
About The Company : EUROAPI focuses on reinventing active ingredient solutions to sustainably meet the needs of customers and patients worldwide. The company is a leading API playe...
CAS Number : 75128-73-3
End Use API : Acyclovir
About The Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns tw...
(2S, 5S)-1yl amino)-3-methyl butanoyl) -5- Methyl ...
CAS Number : 59278-00-1
End Use API : Acyclovir
About The Company : Arde’s Laboratories Pvt Ltd. is a specialty pharmaceutical company that is engaged in the development, manufacture and marketing of generic pharmaceutical dru...

2-Oxa-1,4-butanediol diacetate
CAS Number : 59278-00-1
End Use API : Acyclovir
About The Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (AP...

CAS Number : 75128-73-3
End Use API : Acyclovir
About The Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (AP...

CAS Number : 75128-73-3
End Use API : Acyclovir
About The Company : Keminntek Laboratories is a Hyderabad (India) based Contract Research Organization in Pharmaceutical sector in specific Pharmaceutical Intermediates, Speciality...

CAS Number : 75123-73-3
End Use API : Acyclovir
About The Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and imp...

2-(4-ethyl-3-iodophenyl)-2-Methylpropanoic acid
CAS Number : 1256584-73-2
End Use API : Acyclovir
About The Company : Shanghai Stepuppharm has a strong technical development troop and most of our technological backbone are Senior R&D persons and have more than 10 years experien...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
17
PharmaCompass offers a list of Acyclovir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acyclovir manufacturer or Acyclovir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acyclovir manufacturer or Acyclovir supplier.
PharmaCompass also assists you with knowing the Acyclovir API Price utilized in the formulation of products. Acyclovir API Price is not always fixed or binding as the Acyclovir Price is obtained through a variety of data sources. The Acyclovir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aciclovirum [Latin] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aciclovirum [Latin], including repackagers and relabelers. The FDA regulates Aciclovirum [Latin] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aciclovirum [Latin] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aciclovirum [Latin] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aciclovirum [Latin] supplier is an individual or a company that provides Aciclovirum [Latin] active pharmaceutical ingredient (API) or Aciclovirum [Latin] finished formulations upon request. The Aciclovirum [Latin] suppliers may include Aciclovirum [Latin] API manufacturers, exporters, distributors and traders.
click here to find a list of Aciclovirum [Latin] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aciclovirum [Latin] DMF (Drug Master File) is a document detailing the whole manufacturing process of Aciclovirum [Latin] active pharmaceutical ingredient (API) in detail. Different forms of Aciclovirum [Latin] DMFs exist exist since differing nations have different regulations, such as Aciclovirum [Latin] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aciclovirum [Latin] DMF submitted to regulatory agencies in the US is known as a USDMF. Aciclovirum [Latin] USDMF includes data on Aciclovirum [Latin]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aciclovirum [Latin] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aciclovirum [Latin] suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Aciclovirum [Latin] Drug Master File in Japan (Aciclovirum [Latin] JDMF) empowers Aciclovirum [Latin] API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Aciclovirum [Latin] JDMF during the approval evaluation for pharmaceutical products. At the time of Aciclovirum [Latin] JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Aciclovirum [Latin] suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aciclovirum [Latin] Drug Master File in Korea (Aciclovirum [Latin] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aciclovirum [Latin]. The MFDS reviews the Aciclovirum [Latin] KDMF as part of the drug registration process and uses the information provided in the Aciclovirum [Latin] KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aciclovirum [Latin] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aciclovirum [Latin] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aciclovirum [Latin] suppliers with KDMF on PharmaCompass.
A Aciclovirum [Latin] CEP of the European Pharmacopoeia monograph is often referred to as a Aciclovirum [Latin] Certificate of Suitability (COS). The purpose of a Aciclovirum [Latin] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Aciclovirum [Latin] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Aciclovirum [Latin] to their clients by showing that a Aciclovirum [Latin] CEP has been issued for it. The manufacturer submits a Aciclovirum [Latin] CEP (COS) as part of the market authorization procedure, and it takes on the role of a Aciclovirum [Latin] CEP holder for the record. Additionally, the data presented in the Aciclovirum [Latin] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Aciclovirum [Latin] DMF.
A Aciclovirum [Latin] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Aciclovirum [Latin] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Aciclovirum [Latin] suppliers with CEP (COS) on PharmaCompass.
A Aciclovirum [Latin] written confirmation (Aciclovirum [Latin] WC) is an official document issued by a regulatory agency to a Aciclovirum [Latin] manufacturer, verifying that the manufacturing facility of a Aciclovirum [Latin] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Aciclovirum [Latin] APIs or Aciclovirum [Latin] finished pharmaceutical products to another nation, regulatory agencies frequently require a Aciclovirum [Latin] WC (written confirmation) as part of the regulatory process.
click here to find a list of Aciclovirum [Latin] suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aciclovirum [Latin] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aciclovirum [Latin] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aciclovirum [Latin] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aciclovirum [Latin] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aciclovirum [Latin] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aciclovirum [Latin] suppliers with NDC on PharmaCompass.
Aciclovirum [Latin] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aciclovirum [Latin] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aciclovirum [Latin] GMP manufacturer or Aciclovirum [Latin] GMP API supplier for your needs.
A Aciclovirum [Latin] CoA (Certificate of Analysis) is a formal document that attests to Aciclovirum [Latin]'s compliance with Aciclovirum [Latin] specifications and serves as a tool for batch-level quality control.
Aciclovirum [Latin] CoA mostly includes findings from lab analyses of a specific batch. For each Aciclovirum [Latin] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aciclovirum [Latin] may be tested according to a variety of international standards, such as European Pharmacopoeia (Aciclovirum [Latin] EP), Aciclovirum [Latin] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aciclovirum [Latin] USP).